Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$85.2M |
| 2 |
Zillow
Z
|
+$72.7M |
| 3 |
Global Payments
GPN
|
+$69.5M |
| 4 |
Icon
ICLR
|
+$62.2M |
| 5 |
Danaher
DHR
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$108M |
| 2 |
Meta Platforms (Facebook)
META
|
+$77.7M |
| 3 |
Cigna
CI
|
+$54.5M |
| 4 |
Western Digital
WDC
|
+$38.4M |
| 5 |
Expedia Group
EXPE
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.55% |
| 2 | Technology | 13.23% |
| 3 | Industrials | 11.63% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Communication Services | 3.06% |
Similar funds
Glenview Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Glenview Capital Management held 61 positions worth $4.49B, up 26% from $3.57B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Glenview Capital Management deployed $682M of net new capital in Q3 2025, opening 18 new positions and adding to 19 existing holdings. Its largest new stake was Zillow: 889,666 shares worth $68.5M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 51% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Tenet Healthcare, an estimated $108M trimmed.
- Glenview Capital Management's largest Q3 2025 buy was Zillow: 889,666 shares worth $68.5M.
- Glenview Capital Management added most to Thermo Fisher Scientific in Q3 2025, an estimated $85.2M increase.
- Glenview Capital Management's biggest Q3 2025 reduction was Tenet Healthcare, cutting an estimated $108M.
- Glenview Capital Management fully exited Western Digital in Q3 2025, selling an estimated $38.4M.
- Glenview Capital Management's ten largest holdings make up 65% of its $4.49B portfolio in Q3 2025.
- Glenview Capital Management opened 18 new positions and closed 7 in Q3 2025.
- Glenview Capital Management's portfolio value rose 26% quarter-over-quarter to $4.49B.
Based on Glenview Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.